Start: January 2016
End: December 2021
Enrollment: 232
This study will identify reliable methods for tracking the progression of corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and oligosymptomatic/variant progressive supranuclear palsy (o/vPSP) over time. Researchers will conduct a variety of tests, including brain imaging, eye movement, retinal imaging, blood and cerebrospinal fluid samples, and measurements of cognitive function. The results of this study may help the development of treatments for these neurological diseases. The study will also provide information about how brain imaging techniques for diagnosis compare with testing blood, urine, and cerebrospinal fluids.
Minimum Age: 40 Years
Maximum Age: 80 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
California | |
---|---|
University of California, San Diego (UCSD)
San Diego, CA 92037
Recruiting
Ileana Rubio |
|
University of California, San Francisco (UCSF)
San Francisco, CA 94158
Recruiting
Stephanie Vento, BS |
|
Maryland | |
Johns Hopkins University
Baltimore, MD 21287
Recruiting
Diane Lanham |
|
Massachusetts | |
Harvard University - Massachusetts General Hospital
Charlestown, MA 02129
Recruiting
Samantha Krivensky, BA |
|
Minnesota | |
Mayo Clinic - Rochester
Rochester, MN 55905
Recruiting
Ruth Kraft |
|
New York | |
Columbia University
New York, NY 10032
Recruiting
Masood Manoochehri |
|
Pennsylvania | |
University of Pennsylvania
Philadelphia, PA 19104
Recruiting
Dahlia Kamel |
Lead: University of California, San Francisco
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT02966145
An official website of the U.S. government, managed by the National Institutes on Aging at the National Institutes of Health